Predict your next investment

Angel Investor (Group)
biopacificinvestors.com

See what CB Insights has to offer

Investments

5

About BioPacific Investors

BioPacific Investors is a new angel investment group created to leverage cross-border opportunities in early-stage life science and healthcare. Will focus on US-based life science and healthcare companies with China/Asia as a key component of their business strategy. Seed or Series A funding of $250K to $1M. Access to government and VC follow-on funding in China. No fee to apply or present, but subject to screening process approval.

BioPacific Investors Headquarter Location

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BioPacific Investors Investments

5 Investments

BioPacific Investors has made 5 investments. Their latest investment was in Qool Therapeutics as part of their Series A on February 2, 2017.

CBI Logo

BioPacific Investors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/23/2017

Series A

Qool Therapeutics

$8M

Yes

2

7/25/2012

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

4/18/2011

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Date

2/23/2017

7/25/2012

4/18/2011

Round

Series A

Series B - II

Series B

Other Investors

Other Investors

Company

Qool Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$8M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

0

0

BioPacific Investors Acquisitions

1 Acquisition

BioPacific Investors acquired 1 company. Their latest acquisition was Horizon Sciences on March 17, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/17/2009

$99M

Acq - Fin

2

Date

3/17/2009

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acq - Fin

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.